Загрузка...
Immunotherapy Discontinuation in Metastatic Melanoma: Lessons from Real-Life Clinical Experience
SIMPLE SUMMARY: Metastatic melanoma patients derive unprecedented benefit from immunotherapy, and some of them are even considered cured. Currently, there is no consensus on the safety nor on the timing of treatment discontinuation in this population. This is a real-world study on 106 advanced melan...
Сохранить в:
| Опубликовано в: : | Cancers (Basel) |
|---|---|
| Главные авторы: | , , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
MDPI
2021
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8234591/ https://ncbi.nlm.nih.gov/pubmed/34203061 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers13123074 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|